Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
about
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).The many faces of FcγRI: implications for therapeutic antibody function.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications.FcγRI (CD64): an identity card for intestinal macrophages.A Low Neutrophil CD64 Index Is Associated with Sustained Remission During Infliximab Maintenance Therapy.Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?Validation of Neutrophil CD64 Blood Biomarkers to Detect Mucosal Inflammation in Pediatric Crohn's Disease.Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis.Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies.Update on Neutrophil Function in Severe Inflammation
P2860
Q34117832-1A3091AF-E6D6-4A22-9470-1E5883FCE55AQ34488394-EF8638E7-1660-4B89-BE6A-FB30BE9B7846Q38615362-118352F2-E316-4FE9-B86B-900CA73BC9B1Q38763702-E19B36FA-C5CC-474D-85ED-A45F318CA278Q38927751-60F7E6FC-62EC-4A94-94E5-98CDFB6214C6Q38950036-A9D30604-856E-4959-8667-6FC1B7C262D4Q38979811-1D729C4E-9782-4A8F-87A8-DD0044ED1932Q40381598-EE50D1FB-CDBC-47A3-8644-001AA171EA48Q42759481-D172FFB3-F378-4C1F-B139-21EB67314394Q43988900-D1511211-8777-420C-8ED5-B55D60CC2A09Q44379124-70B0BB49-3F8B-4A00-AB38-ECF0FE6700F1Q49616319-D63B17A8-BFE4-40C1-8D99-9FA0FB41028AQ51314320-9EF88C5B-5679-4BB9-80E1-C40DBA15691DQ52320824-42B1A38F-E0CD-4A7B-B335-5B6CF307B77EQ52362617-7F065D9E-6F5F-4A95-B670-7F320B7B3C6CQ54988566-24711AC5-2D27-4F68-B5CE-ABC5120BC59CQ57818269-0D4588CE-9683-44C0-911E-5C0B1390F5E1
P2860
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@ast
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@en
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@nl
type
label
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@ast
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@en
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@nl
prefLabel
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@ast
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@en
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@nl
P2093
P2860
P1433
P1476
Fc gamma receptor CD64 modulates the inhibitory activity of infliximab
@en
P2093
Achim Weber
Gerd A Kullak-Ublick
Jyrki J Eloranta
Kacper A Wojtal
Luc Biedermann
Michael Fried
Michael Scharl
Pascal Frei
Stephan R Vavricka
P2860
P304
P356
10.1371/JOURNAL.PONE.0043361
P407
P577
2012-01-01T00:00:00Z